Porównaj metody

	Zrewidowany Test Identyfikacji Zaburzeń Związanych z Używaniem Konopi (CUDIT-R)	Brief Addiction Monitor (BAM)
Dziedzina	Medycyna uzależnień	Medycyna uzależnień
Rodzina	Process / pipeline	Process / pipeline
Rok powstania	2010	2013
Twórca	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman	Cacciola, Alterman, Drapkin, Valadez
Typ	Self-report	Self-report
Źródło pierwotne	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.
Inne nazwy	CUDIT-R, CUDIT	BAM
Pokrewne	4	4
Podsumowanie	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.